PneumoRecs VaxAdvisor
PneumoRecs VaxAdvisor generates an estimated $0/month in revenue from 30–200 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-10-03).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 30–200 |
| Estimate confidence | medium |
| Pricing | Free |
| Rating | 3.37 ★ (60 ratings) |
| Category | Medical |
| Released | 14.12.2018 |
| App last updated | 21.08.2025 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · medium confidence
About
This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 7Ratings & velocity
★ 0 in windowRating distribution
58% positive · 60 ratingsGeographic reach
best rank · 0 storefrontsRevenue & downloads trend
ARPU $0Update history
1 update tracked- v3.31.1y ago
Minor edits.
PneumoRecs VaxAdvisor — FAQ
How many downloads does PneumoRecs VaxAdvisor get?
PneumoRecs VaxAdvisor sees an estimated 30–200 downloads per month on the App Store, per AppCurrents modeling.
Is PneumoRecs VaxAdvisor free?
PneumoRecs VaxAdvisor is free to download on the App Store, with no in-app purchases detected.
What is PneumoRecs VaxAdvisor's rating?
PneumoRecs VaxAdvisor holds a 3.37-star average from 60 ratings on the App Store.
When was PneumoRecs VaxAdvisor released?
PneumoRecs VaxAdvisor launched on the App Store on 14.12.2018. Its latest version shipped 21.08.2025.
